Hence, we worked with RXRA ligands 9cRA, Aci, and bexarotene, which improved IM sensitivity in CML bulk and CML CD34+ cells but had minimal effect on HD CD34+ cells and PBMNCs. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.